FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/HIV.C.DE112

Packagesmart.who.int.hiv
Resource TypeValueSet
IdHIV.C.DE112
FHIR VersionR4
Sourcehttp://smart.who.int/hiv/https://build.fhir.org/ig/WorldHealthOrganization/smart-hiv/ValueSet-HIV.C.DE112.html
URLhttp://smart.who.int/hiv/ValueSet/HIV.C.DE112
Version0.4.4
Statusactive
Date2025-07-24T19:24:35+00:00
NameHIVCDE112
TitleContraindications to PrEP usage ValueSet
Authoritywho
DescriptionValue set of listing of contraindications to pre-exposure prophylaxis (PrEP)

Resources that use this resource

StructureDefinition
HIVCPrEPvisitHIV.C PrEP visit

Resources that this resource uses

CodeSystem
HIVConceptsWHO SMART HIV Concepts CodeSystem

Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: ValueSet HIV.C.DE112

  • Include these codes as defined in http://smart.who.int/hiv/CodeSystem/HIVConcepts
    CodeDisplayDefinition
    HIV.C.DE113Tenofovir disoproxil fumarate (TDF) allergy or contraindicationAllergy to pre-exposure prophylaxis (PrEP) tenofovir disoproxil fumarate (TDF)
    HIV.C.DE114HIV-positiveClient is HIV-positive
    HIV.C.DE115Low estimated creatinine clearanceEstimated creatinine clearance of less than 60 ml/min (if known)
    HIV.C.DE116Acute HIV infection symptomsSymptoms that could suggest an acute HIV infection
    HIV.C.DE117Probable recent exposure to HIVWhen the client is reported to have had probable recent exposure to HIV
    HIV.C.DE118Other allergy or contraindication to a medicine in the PrEP regimenClient has another allergy or contraindication to a medicine in the pre-exposure prophylaxis (PrEP) regimen

Source

{
  "resourceType": "ValueSet",
  "id": "HIV.C.DE112",
  "meta": {
    "profile": [
      "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareablevalueset",
      "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishablevalueset",
      "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-computablevalueset"
    ]
  },
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "url": "http://smart.who.int/hiv/ValueSet/HIV.C.DE112",
  "version": "0.4.4",
  "name": "HIVCDE112",
  "title": "Contraindications to PrEP usage ValueSet",
  "status": "active",
  "experimental": true,
  "date": "2025-07-24T19:24:35+00:00",
  "publisher": "WHO",
  "contact": [
    {
      "name": "WHO",
      "telecom": [
        {
          "system": "url",
          "value": "http://who.int"
        }
      ]
    }
  ],
  "description": "Value set of listing of contraindications to pre-exposure prophylaxis (PrEP)",
  "compose": {
    "include": [
      {
        "system": "http://smart.who.int/hiv/CodeSystem/HIVConcepts",
        "concept": [
          {
            "code": "HIV.C.DE113",
            "display": "Tenofovir disoproxil fumarate (TDF) allergy or contraindication"
          },
          {
            "code": "HIV.C.DE114",
            "display": "HIV-positive"
          },
          {
            "code": "HIV.C.DE115",
            "display": "Low estimated creatinine clearance"
          },
          {
            "code": "HIV.C.DE116",
            "display": "Acute HIV infection symptoms"
          },
          {
            "code": "HIV.C.DE117",
            "display": "Probable recent exposure to HIV"
          },
          {
            "code": "HIV.C.DE118",
            "display": "Other allergy or contraindication to a medicine in the PrEP regimen"
          }
        ]
      }
    ]
  }
}